Fig. 1
From: Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
Typical 18F-FDG PET/CT images of the ascending aorta wall uptake at baseline and after 6 months of biologic therapy. Axial and coronal images of ascending aorta from a 65-year-old female patient who underwent treatment with infliximab. A At baseline, the mean SUVmax was 1.64, and the TBR was 1.63. B At 6 months, the mean SUVmax was 1.56, and the TBR was 1.44. SUVmax, maximum standardized uptake value; TBR, target-to-background ratio